| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2003;41:688.)
© 2003 American Heart Association, Inc.
Scientific Contributions |
From the Hypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital (H.W., O.A.C., J.L.G.), Detroit, Mich; and Department of Cardiology, Zhongnan Hospital of Wuhan University (H.W.), Wuhan, Peoples Republic of China.
Correspondence to Jeffrey L. Garvin, PhD, Hypertension and Vascular Research Division, Department of Internal Medicine, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202. E-mail jgarvin1{at}hfhs.org
| Abstract |
|---|
|
|
|---|
Key Words: nitric oxide rabbit tubuloglomerular feedback afferent arteriole loop of Henle
| Introduction |
|---|
|
|
|---|
NO produced by neuronal NO synthase (nNOS) in the macula densa blunts TGF. Increasing luminal NaCl concentration increases nNOS activity and NO production, as evidenced by inhibitor studies611 and direct measurements of macula densa NO.12 Presently, the mechanism by which nNOS in the macula densa is activated is unclear. One possible mechanism is via changes in intracellular pH (pHi). NOS activity is strongly pH-dependent, reaching a maximum at a pH of
7.5 to 8.0.13,14 Physiological changes in pHi can have profound effects on nNOS activity and NO production, even in the presence of saturating concentrations of Ca2+ and its cofactors.14 Such increases in nNOS activity may be owing to the rise in pHi caused by increasing luminal NaCl and activation of Na+/H+ exchange. Consequently, we hypothesized that inhibiting apical Na+/H+ exchange in macula densa cells blunts the activation of nNOS caused by a change in luminal NaCl concentration and augments TGF by reducing NO production.
| Methods |
|---|
|
|
|---|
The bath was minimum essential medium containing 0.15% BSA and was exchanged continuously at a rate of 1 mL/min. Microdissection and cannulation were completed at 8°C, after which the bath was gradually warmed to 37°C. Once temperature was stable, a 30-minute equilibration period was allowed before any measurements were taken.
The macula densa was microperfused with low-NaCl solution (10 mmol/L Na+; 9 mmol/L Cl-) containing (in mmol/L): 10 HEPES, 1 CaCO3, 0.5 K2HPO4, 4 KHCO3, 1.2 MgSO4, 5.5 glucose, 0.5 sodium acetate, and 0.5 sodium lactate (pH 7.4). The high-NaCl solution had the same composition except that 79 mmol/L NaCl was added; thus, the final concentration was 80 mmol/L Na+ and 79 mmol/L Cl-.
Images were displayed at magnifications up to 1980x and recorded with a Sony video system consisting of a camera (DXC-755), monitor (PVM1342Q), and video recorder (EDV-7500). We defined TGF as the change in afferent arteriole diameter when the NaCl concentration perfusing the macula densa was increased from low to high. Diameter was measured with an image analysis system (Universal Imaging).
Dimethyl amiloride (Sigma) was prepared daily as a 10 mmol/L stock in warm perfusion solution and diluted to 100 µmol/L just before the experiment. 7-Nitroindazole (7-NI; Cayman), an inhibitor of nNOS, was dissolved in 98% alcohol by sonication. The final alcohol concentration was 0.018%, which in preliminary experiments did not affect TGF response. 7-NI has been shown to be a selective inhibitor of macula densa nNOS both in experiments using isolated perfused juxtaglomerular apparatus9,10,17 and the in vivo micropuncture preparation.68,11
Statistics
Data are expressed as mean±SEM. Data were analyzed using ANOVA for repeated measures. Post-hoc testing was performed by using paired t tests. Hochbergs method was used to adjust for multiple testing. P<0.05 was considered significant.
| Results |
|---|
|
|
|---|
|
To investigate whether blocking apical Na+/H+ exchange augments TGF, we compared TGF responses before and after inhibiting apical Na+/H+ exchange with dimethyl amiloride (100 µmol/L). During the control period, afferent arteriole diameter decreased from 15.7±0.3 to 13.2±0.4 µm when the luminal NaCl concentration was increased. After dimethyl amiloride was added to the macula densa perfusate, diameter decreased from 15.5±0.4 to 11.8±0.6 µm. Thus, blocking apical Na+/H+ exchange increased the TGF response from 2.5±0.3 to 3.7±0.5 µm (P<0.01; n=6) Control experiments showed no significant change in TGF response with time (Figure 2).
|
Next, we investigated whether the increase in TGF caused by inhibiting NO production by nNOS requires a functional apical Na+/H+ exchanger. For this, we tested the effect of the nNOS inhibitor 7-NI on TGF with dimethyl amiloride present in the macula densa perfusate. In the presence of 100 µmol/L dimethyl amiloride, afferent arteriole diameter decreased from 16.7±0.7 to 14.1±0.8 µm when the luminal NaCl concentration was increased. After we added 7-NI (10 µmol/L) to the macula densa lumen with dimethyl amiloride present, diameter decreased from 16.6±0.8 to 13.9±0.8 µm when the luminal NaCl concentration was increased. Thus, TGF response was unchanged by nNOS inhibition after blocking apical Na+/H+ exchange with dimethyl amiloride (2.6±0.2 versus 2.7±0.2 µm; P>0.4; n=6) (Figure 3).
|
| Discussion |
|---|
|
|
|---|
There are several possible explanations for our data. First, apical Na+/H+ exchangers may be directly linked to nNOS via protein/protein interactions. Although not reported for nNOS, both inducible and endothelial NOS are regulated through interactions involving a number of regulatory proteins. Second, nNOS activation may be linked to sodium influx. However, this seems unlikely because the Na+/H+ exchanger only transports a small fraction of the sodium that enters the cell when luminal NaCl concentration is elevated, whereas most sodium enters via the Na/K/2Cl cotransporter.5,22 Changes in intracellular calcium are also a possibility, because nNOS is activated by an increase in intracellular calcium. However, both increases and decreases in intracellular calcium in the macula densa have been reported when the luminal NaCl concentration rises. The last possibility is a change in pHi.
Perfusion of the macula densa lumen with solutions containing high concentrations of sodium leads to an increase in NO production12 and rapid alkalinization of macula densa cytoplasm.15 For instance, when luminal sodium is increased, pH rises from
7.2 to between 7.4 and 7.8 depending on the increase in NaCl.1,2,5 This increase in pH has been attributed to activation of apical amiloride-sensitive Na+/H+ exchange.15 Production of NO by nNOS is strongly pH-dependent.13,14 The enzyme has maximal activity at a pH of
8.13 NOS activity increases 5-fold with alkalinization across a physiologically relevant range.23 Therefore, our data may be explained as follows. Increasing the NaCl concentration at the macula densa stimulates Na+/H+ exchange owing to a large inward-directed sodium gradient. Activation of the exchanger results in alkalinization of the macula densa. The increase in pH enhances nNOS activity and NO production. The increased NO levels blunt TGF.
In vitro studies9,10 have shown that inhibiting nNOS only affects afferent arteriole diameter when the NaCl concentration in the macula densa is high. These data indicate that nNOS is inactive when luminal sodium is low and is activated when the sodium concentration increases. In vivo micropuncture experiments show analogous results.68,11 Furthermore, direct measurements of NO have shown that NO production increases with an increase in NaCl in the lumen of the macula densa.12 Our data offer a possible explanation for such findings. With low sodium concentrations in the macula densa lumen, nNOS cannot affect TGF because there is little or no NO production owing to the relatively acidic pH of the macula densa.
Perspectives
In summary, blocking Na+/H+ exchange in the macula densa lumen significantly enhanced TGF. By itself the nNOS inhibitor 7-NI in the macula densa lumen augmented TGF, but in the presence of a Na+/H+ exchange inhibitor, dimethyl amiloride, 7-NI had no effect on TGF. These data indicate that inhibiting apical Na+/H+ exchange in the macula densa mimics the effect of inhibiting NO production by nNOS in the macula densa on TGF. Thus, it is possible that increased apical Na+/H+ exchange caused by increasing the sodium concentration in the lumen of the macula densa activates macula densa nNOS. The link between nNOS and Na+/H+ exchange may be an increase in pHi caused by the latter; however, we did not measure changes in macula densa pH in this study. This may provide a feedback mechanism that prevents extreme TGF responses. Our data may also explain why macula densa nNOS inhibition has no effect on afferent arteriole diameter when the NaCl concentration in the macula densa lumen is low.
| Acknowledgments |
|---|
Received October 9, 2002; first decision October 28, 2002; accepted November 14, 2002.
| References |
|---|
|
|
|---|
2. Peti-Peterdi J, Bell PD. Regulation of macula densa Na: H exchange by angiotensin II. Kidney Int. 1998; 54: 20212028.[CrossRef][Medline] [Order article via Infotrieve]
3. Lapointe J-Y, Laamarti A, Bell PD. Ionic transport in macula densa cells. Kidney Int. 1998; 54 (Suppl 67): S58S64.
4. Bell PD, Lapointe J-Y. Characteristics of membrane transport processes of macula densa cells. Clin Exp Pharmacol Physiol. 1997; 24: 541547.[Medline] [Order article via Infotrieve]
5. Fowler BC, Chang Y-S, Laamarti A, Higdon M, Lapointe J-Y, Bell PD. Evidence for apical sodium proton exchange in macula densa cells. Kidney Int. 1995; 47: 746751.[Medline] [Order article via Infotrieve]
6. Thorup C, Persson AEG. Macula densa derived nitric oxide in regulation of glomerular capillary pressure. Kidney Int. 1996; 49: 430436.[Medline] [Order article via Infotrieve]
7. Welch WJ, Tojo A, Wilcox CS. Role of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol Renal Physiol. 2000; 278: F769F776.
8. Welch WJ, Wilcox CS. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR. Kidney Int. 2001; 59: 12571263.[CrossRef][Medline] [Order article via Infotrieve]
9. Ren Y, Garvin JL, Ito S, Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int. 2001; 60: 16761683.[CrossRef][Medline] [Order article via Infotrieve]
10. Wang H, Carretero OA, Garvin JL. Nitric oxide produced by THAL nitric oxide synthase inhibits TGF. Hypertension. 2001; 39: 662666.
11. Welch WJ, Tojo A, Lee J-U, Kang DG, Schnackenberg CG, Wilcox CS. Nitric oxide synthase in the JGA of the SHR: expression and role in tubuloglomerular feedback. Am J Physiol. 1999; 277: F130F138.
12. Liu R, Pittner J, Persson AEG. Changes of cell volume and nitric oxide concentration in macula densa cells caused by changes in luminal NaCl concentration. J Am Soc Nephrol. 2002; 13: 26882696.
13. Wilcox CS. L-arginine-nitric oxide pathway. In: Seldin DW, Giebisch G, eds. The Kidney: Physiology and Pathophysiology, 3rd ed. New York: Raven Press; 2000: 849871.
14. Gorren ACF, Schrammel A, Schmidt K, Mayer B. Effects of pH on the structure and function of neuronal nitric oxide synthase. Biochem J. 1998; 331: 801807.
15. Wang H, Garvin JL, Carretero OA. Angiotensin II enhances tubuloglomerular feedback via luminal AT1 receptors on the macula densa. Kidney Int. 2001; 60: 18511857.[CrossRef][Medline] [Order article via Infotrieve]
16. Ito S, Carretero OA. An in vitro approach to the study of macula densamediated glomerular hemodynamics. Kidney Int. 1990; 38: 12061210.[Medline] [Order article via Infotrieve]
17. Ren Y, Garvin JL, Carretero OA. Role of macula densa nitric oxide and cGMP in the regulation of tubuloglomerular feedback. Kidney Int. 2000; 58: 20532060.[CrossRef][Medline] [Order article via Infotrieve]
18. Thorup C, Persson AEG. Inhibition of locally produced nitric oxide resets tubuloglomerular feedback mechanism. Am J Physiol. 1994; 267: F606F611.
19. Wilcox CS. Role of macula densa NOS in tubuloglomerular feedback. Nephrol Hypertens. 1998; 7: 443449.[CrossRef]
20. Braam B, Koomans HA. Nitric oxide antagonizes the actions of angiotensin II to enhance tubuloglomerular feedback responsiveness. Kidney Int. 1995; 48: 14061411.[Medline] [Order article via Infotrieve]
21. Welch WJ, Wilcox CS. Role of nitric oxide in tubuloglomerular feedback: effects of dietary salt. Clin Exp Pharmacol Physiol. 1997; 24: 582586.[Medline] [Order article via Infotrieve]
22. Lapointe J-Y, Bell PD, Cardinal J. Direct evidence for apical Na+:2Cl-:K+ cotransport in macula densa cells. Am J Physiol. 1990; 258: F1466F1469.
23. Yaqoob M, Edelstein CL, Wieder ED, Alkhunaizi AM, Gengaro PE, Nemenoff RA, Schrier RW. Nitric oxide kinetics during hypoxia in proximal tubules: effects of acidosis and glycine. Kidney Int. 1996; 49: 13141319.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
F. Hanner, R. Chambrey, S. Bourgeois, E. Meer, I. Mucsi, L. Rosivall, G. E. Shull, J. N. Lorenz, D. Eladari, and J. Peti-Peterdi Increased renal renin content in mice lacking the Na+/H+ exchanger NHE2 Am J Physiol Renal Physiol, April 1, 2008; 294(4): F937 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Orlov and A. A. Mongin Salt-sensing mechanisms in blood pressure regulation and hypertension Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2039 - H2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Lorenz, I. Dostanic-Larson, G. E. Shull, and J. B. Lingrel Ouabain Inhibits Tubuloglomerular Feedback in Mutant Mice with Ouabain-Sensitive {alpha}1 Na,K-ATPase J. Am. Soc. Nephrol., September 1, 2006; 17(9): 2457 - 2463. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Herrera and J. L. Garvin Recent Advances in the Regulation of Nitric Oxide in the Kidney Hypertension, June 1, 2005; 45(6): 1062 - 1067. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Komlosi, S. Frische, A. L. Fuson, A. Fintha, A. Zsembery, J. Peti-Peterdi, and P. D. Bell Characterization of basolateral chloride/bicarbonate exchange in macula densa cells Am J Physiol Renal Physiol, February 1, 2005; 288(2): F380 - F386. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Kovacs, P. Komlosi, A. Fuson, J. Peti-Peterdi, L. Rosivall, and P. D. Bell Neuronal Nitric Oxide Synthase: Its Role and Regulation in Macula Densa Cells J. Am. Soc. Nephrol., October 1, 2003; 14(10): 2475 - 2483. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |